Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

• Main Authors: Frederick Berro Rivera (Author), Linnaeus Louisse A. Cruz (Author), John Vincent Magalong (Author), Jade Monica Marie J. Ruyeras (Author), John Paul Aparece (Author), Nathan Ross B. Bantayan (Author), Kyla Lara-Breitinger (Author), Martha Gulati (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Multiple cardiovascular outcomes trials (CVOTs) have shown the efficacy of GLP-1RAs in reducing major adverse cardiovascular events (MACEs) for high-risk patients. However, some CVOTs failed to demonstrate cardiovascular benefits. Objectives: We analyzed the impact of GLP-1RA on cardiova...